SecBot SecBot
PRESS-RELEASE ·Filed May 6, 2026

TKNO

Alpha Teknova, Inc.
BULLISH
Impact 7/10
Horizondays Processed5mo ago WireGlobeNewswire
Press release · Earnings
Actionable Insight ▲ Bullish

Investors should watch for continued Clinical Solutions momentum and cash burn trajectory. Upcoming conference presentations (Craig-Hallum May 28, William Blair June 4) may provide further catalysts. The reaffirmed guidance reduces near-term downside risk.

DirectionBullish
Confidencehigh
Horizondays
Final — all horizons settled through T+60d
TKNO ▲ +32.50% at T+60d
LONG call ✓ call won +32.50% · α vs SPY +28.67% · entry $4.00 → $5.30
Entry = T+0 close
May 6, 2026
via day close
T+1d
0.00%
call 0.00% · α -0.83%
$4.00
settled 6mo ago
T+5d
-2.25%
call -2.25% · α -3.75%
$3.91
settled 6mo ago
T+20d
+28.25%
call +28.25% · α +25.11%
$5.13
settled 5mo ago
T+60d
+32.50%
call +32.50% · α +28.67%
$5.30
settled 3mo ago

Price Chart

Loading chart...

Executive Summary

Alpha Teknova reported Q1 2026 revenue of $11.1M (beat consensus of $10.2M by 8.6%) and EPS of -$0.08 (beat consensus -$0.09 by 11.1%). Revenue grew 13% YoY, driven by 85% growth in Clinical Solutions, while gross margin expanded to 34.2% from 30.7%. The company reaffirmed full-year 2026 revenue guidance of $42-44M and expects free cash outflow below $10M.

Key Financial Metrics

EPS
−$0.08
est −$0.09 · +11.1%
Revenue
$11.1M
est $10.2M · +8.6% · +13.1% YoY
Rating
beat
Guidance
$42M-$44M
maintained
Free Cash Flow
-$3.6M
Gross Margin
34.2%

Key Facts

  • Q1 2026 revenue $11.1M vs $9.8M YoY (+13%)
  • EPS -$0.08 vs -$0.09 YoY
  • Clinical Solutions revenue up 85% to $2.1M
  • Gross margin 34.2% vs 30.7% YoY
  • Reaffirmed FY2026 revenue guidance $42-44M
  • Cash and investments $17.8M, debt $13.2M
  • Free cash outflow improved to $3.6M from $4.3M

Financial Impact

Revenue beat consensus by ~$0.9M; EPS beat by $0.01

revenueepsgross marginfree cash flow

Risk Factors

  • Still unprofitable with accumulated deficit of $140M
  • Cash burn $3.6M in Q1; runway limited given $17.8M cash
  • Guidance maintained, not raised, limiting upside surprise potential

Market Snapshot

Exchange
Nasdaq
Sector
In Vitro & In Vivo Diagnostic Substances
Analyst Consensus
75% bullish (12 analysts)

Investment Themes

Documents Analyzed

This report is based on 1 press release from GlobeNewswire.

DocumentAccession Number
PRESS-RELEASE Data (Synthetic)press-3289305
10 reports for TKNO
Performance horizon
25% Hit rate @ T+1 1 of 4 directional calls Went positive at some point 1 of 4 best @ T+60▲ +154.50%Mar 6, 2026
Filters
Rows
Reports for TKNO — sortable, filterable
TypeNow
Oct 21, 2026
4d ago
Press Release
NEUTRAL ★ 1/10
$6.15 $6.42▲ +4.39%▲ +4.91%$6.59 (+7.15%)
Oct 21, 2026
5d ago
8-K
MIXED ★ 6/10
$6.15 $6.42▲ +4.39%▲ +4.91%$6.59 (+7.15%)
Oct 21, 2026
5d ago
424B5
BEARISH ★ 6/10
$6.15 $6.42▼ −4.39%▼ −4.91%$6.59 (−7.15%)
Oct 20, 2026
6d ago
424B5
BEARISH ★ 6/10
$5.85 $6.15▼ −5.13%▼ −6.31%$6.59 (−12.65%)
Oct 20, 2026
6d ago
Press Release
BEARISH ★ 5/10
$5.85 $6.15▼ −5.13%▼ −6.31%$6.59 (−12.65%)
Oct 20, 2026
6d ago
Press Release
MIXED ★ 6/10
$5.85 $6.15▲ +5.13%▲ +6.31%$6.59 (+12.65%)
Jun 1, 2026
21w ago
8-K
NEUTRAL ★ 2/10
$5.18 $5.13▼ −0.97%▼ −0.24%$6.59 (+27.22%)
May 6, 2026
24w ago
Press Release
BULLISH ★ 7/10
$4.00 $4.00· 0.00%▼ −0.83%$6.59 (+64.75%)
Apr 22, 2026
26w ago
Press Release
NEUTRAL ★ 1/10
$3.03 $3.18▲ +4.95%▲ +4.17%$6.59 (+117.49%)
Mar 6, 2026
33w ago
Insider Cluster
BULLISH ★ 6/10
$2.11 $2.12▲ +0.47%▼ −0.37%$6.59 (+212.32%)
Showing 10 of 10

US Market Status

Market Closed — Opens Tue (15h 56m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published May 6, 2026